Ultrasound zaps brain to unlock new treatments for addiction and pain
NCT ID NCT05147103
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This study explores how different durations of low-intensity focused ultrasound (LIFU) can temporarily change brain activity in healthy adults. Participants undergo brain imaging and then receive ultrasound pulses while muscle responses are measured. The goal is to better understand how this noninvasive technique works, which may one day lead to treatments for addiction, pain, and mental health issues.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Low-Intensity Focused Ultrasound (LIFU)
- What this could lead to
- If successful, this could help develop noninvasive brain stimulation treatments for addiction, pain, and mental health conditions.
- What could go wrong
- This is an early-stage study focused on basic brain responses, not a treatment trial. It may not lead to clinical applications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2022
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Above criteria and must understand and speak English. Exclusion Criteria: * Contraindications to MRI, CT, or TMS 1. Claustrophobia 2. Pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, steel worker, or other implants. 3. Pregnancy 4. Active medical disorder or treatment with potential CNS effects 5. History of neurologic disorder 6. History of head injury resulting in loss of consciousness for \>10 minutes 7. History of alcohol or drug dependence
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Development of lifu for clinical purposes are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Fralin Biomedical Research Institute
Roanoke, Virginia, 24016, United States